tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Cash flow

Compare
4,223 Followers

Recursion Pharmaceuticals Cash Flow

RXRX's free cash flow for Q3 2025 was $-117.60M. For the 2025 fiscal year, RXRX's free cash flow was decreased by $-72.54M and operating cash flow was $-117.36M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -359.17M$ -287.78M$ -83.52M$ -158.61M$ -45.40M
Investing Cash Flow
$ 260.06M$ -10.23M$ 193.25M$ -271.74M$ -8.74M
Financing Cash Flow
$ 304.12M$ 140.13M$ 154.34M$ 458.54M$ 246.13M
End Cash Position
$ 603.02M$ 401.43M$ 559.11M$ 295.35M$ 267.17M
Free Cash Flow
$ -372.87M$ -300.33M$ -120.88M$ -198.41M$ -52.13M
Currency in USD

Recursion Pharmaceuticals Cash Flow